chr19-51746449-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002029.4(FPR1):​c.546C>A​(p.Pro182Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.3 in 1,613,844 control chromosomes in the GnomAD database, including 74,947 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 7316 hom., cov: 31)
Exomes 𝑓: 0.30 ( 67631 hom. )

Consequence

FPR1
NM_002029.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -0.164

Publications

25 publications found
Variant links:
Genes affected
FPR1 (HGNC:3826): (formyl peptide receptor 1) This gene encodes a G protein-coupled receptor of mammalian phagocytic cells that is a member of the G-protein coupled receptor 1 family. The protein mediates the response of phagocytic cells to invasion of the host by microorganisms and is important in host defense and inflammation.[provided by RefSeq, Jul 2010]
FPR1 Gene-Disease associations (from GenCC):
  • susceptibility to localized juvenile periodontitis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 19-51746449-G-T is Benign according to our data. Variant chr19-51746449-G-T is described in ClinVar as Benign. ClinVar VariationId is 402877.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.164 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.45 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FPR1NM_002029.4 linkc.546C>A p.Pro182Pro synonymous_variant Exon 2 of 2 ENST00000304748.5 NP_002020.1 P21462
FPR1NM_001193306.2 linkc.546C>A p.Pro182Pro synonymous_variant Exon 3 of 3 NP_001180235.1 P21462

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FPR1ENST00000304748.5 linkc.546C>A p.Pro182Pro synonymous_variant Exon 2 of 2 1 NM_002029.4 ENSP00000302707.3 P21462
FPR1ENST00000594900.2 linkc.546C>A p.Pro182Pro synonymous_variant Exon 3 of 3 4 ENSP00000470750.2 P21462M0QZT0
FPR1ENST00000595042.5 linkc.546C>A p.Pro182Pro synonymous_variant Exon 3 of 3 2 ENSP00000471493.1 P21462
FPR1ENST00000600815.2 linkc.546C>A p.Pro182Pro synonymous_variant Exon 2 of 2 3 ENSP00000472936.2 P21462M0R315

Frequencies

GnomAD3 genomes
AF:
0.308
AC:
46757
AN:
151862
Hom.:
7306
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.303
Gnomad AMI
AF:
0.180
Gnomad AMR
AF:
0.399
Gnomad ASJ
AF:
0.327
Gnomad EAS
AF:
0.466
Gnomad SAS
AF:
0.332
Gnomad FIN
AF:
0.274
Gnomad MID
AF:
0.282
Gnomad NFE
AF:
0.284
Gnomad OTH
AF:
0.283
GnomAD2 exomes
AF:
0.338
AC:
85060
AN:
251310
AF XY:
0.330
show subpopulations
Gnomad AFR exome
AF:
0.304
Gnomad AMR exome
AF:
0.505
Gnomad ASJ exome
AF:
0.341
Gnomad EAS exome
AF:
0.487
Gnomad FIN exome
AF:
0.298
Gnomad NFE exome
AF:
0.280
Gnomad OTH exome
AF:
0.301
GnomAD4 exome
AF:
0.299
AC:
437211
AN:
1461864
Hom.:
67631
Cov.:
76
AF XY:
0.299
AC XY:
217178
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.299
AC:
10025
AN:
33480
American (AMR)
AF:
0.489
AC:
21857
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.338
AC:
8827
AN:
26136
East Asian (EAS)
AF:
0.480
AC:
19060
AN:
39700
South Asian (SAS)
AF:
0.324
AC:
27961
AN:
86258
European-Finnish (FIN)
AF:
0.291
AC:
15567
AN:
53410
Middle Eastern (MID)
AF:
0.229
AC:
1319
AN:
5768
European-Non Finnish (NFE)
AF:
0.283
AC:
314956
AN:
1111992
Other (OTH)
AF:
0.292
AC:
17639
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
19951
39902
59854
79805
99756
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10770
21540
32310
43080
53850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.308
AC:
46797
AN:
151980
Hom.:
7316
Cov.:
31
AF XY:
0.309
AC XY:
22928
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.303
AC:
12556
AN:
41452
American (AMR)
AF:
0.399
AC:
6093
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.327
AC:
1132
AN:
3464
East Asian (EAS)
AF:
0.466
AC:
2391
AN:
5132
South Asian (SAS)
AF:
0.332
AC:
1594
AN:
4808
European-Finnish (FIN)
AF:
0.274
AC:
2896
AN:
10570
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.284
AC:
19279
AN:
67974
Other (OTH)
AF:
0.287
AC:
606
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1665
3330
4994
6659
8324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.291
Hom.:
16569
Bravo
AF:
0.318
Asia WGS
AF:
0.393
AC:
1363
AN:
3478
EpiCase
AF:
0.270
EpiControl
AF:
0.270

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Gingival disorder Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
1.8
DANN
Benign
0.56
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2070746; hg19: chr19-52249702; COSMIC: COSV59054342; COSMIC: COSV59054342; API